title: Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.
abstract: To discuss and share knowledge around advances in the care of patients with thrombotic disorders, the Third International Symposium of Thrombosis and Anticoagulation was held in São Paulo, Brazil, from October 14-16, 2010. This scientific program was developed by clinicians for clinicians, and was promoted by four major clinical research institutes: the Brazilian Clinical Research Institute, the Duke Clinical Research Institute of the Duke University School of Medicine, the Canadian VIGOUR Centre, and the Uppsala Clinical Research Center. Comprising 3 days of academic presentations and open discussion, the symposium had as its primary goal to educate, motivate, and inspire internists, cardiologists, hematologists, and other physicians by convening national and international visionaries, thought-leaders, and dedicated clinician-scientists. This paper summarizes the symposium proceedings.
authors.affiliation: Duke Clinical Research Institute, Duke University Medical Center, Box 3850, 2400 Pratt Street, Room 0311, Terrace Level, Durham, NC 27705, USA. renato.lopes@duke.edu
authors.forename: Renato D
authors.initials: RD
authors.lastname: Lopes
authors.forename: Richard C
authors.initials: RC
authors.lastname: Becker
authors.forename: John H
authors.initials: JH
authors.lastname: Alexander
authors.forename: Paul W
authors.initials: PW
authors.lastname: Armstrong
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
authors.forename: Mark Y
authors.initials: MY
authors.lastname: Chan
authors.forename: Mark
authors.initials: M
authors.lastname: Crowther
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
authors.forename: Robert A
authors.initials: RA
authors.lastname: Harrington
authors.forename: Elaine M
authors.initials: EM
authors.lastname: Hylek
authors.forename: Stefan K
authors.initials: SK
authors.lastname: James
authors.forename: E Marc
authors.initials: EM
authors.lastname: Jolicoeur
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Mahaffey
authors.forename: L Kristin
authors.initials: LK
authors.lastname: Newby
authors.forename: Eric D
authors.initials: ED
authors.lastname: Peterson
authors.forename: Karen S
authors.initials: KS
authors.lastname: Pieper
authors.forename: Frans
authors.initials: F
authors.lastname: Van de Werf
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin
authors.forename: Harvey D
authors.initials: HD
authors.lastname: White
authors.forename: Antonio C
authors.initials: AC
authors.lastname: Carvalho
authors.forename: Roberto R
authors.initials: RR
authors.lastname: Giraldez
authors.forename: Helio P
authors.initials: HP
authors.lastname: Guimaraes
authors.forename: Helena B
authors.initials: HB
authors.lastname: Nader
authors.forename: Renato A K
authors.initials: RA
authors.lastname: Kalil
authors.forename: Joyce M A
authors.initials: JM
authors.lastname: Bizzachi
authors.forename: Antonio C
authors.initials: AC
authors.lastname: Lopes
authors.forename: David A
authors.initials: DA
authors.lastname: Garcia
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001938:Brazil; D003226:Congresses as Topic; D006801:Humans; D013927:Thrombosis / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000925:Anticoagulants